Login
Vaxcyte, Inc. logo

Vaxcyte, Inc.

vaxcyte.com

What Do They Do?

Develops vaccine candidates to prevent bacterial diseases in adults and children, using a way to make vaccine proteins without cells.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −40% (Loss)
vs −$212.8M in Q3 FY2025

Pipeline emphasis The pneumococcal program's emphasis has moved from the candidate described as the lead in the older report to a different candidate advancing in adult pivotal trials; the earlier lead is being studied in infants.

Who Do They Compete With?

Competes with Pfizer, Merck, GSK, Sanofi, Moderna, VaxForm, BioMVis, Valneva, LimmaTech, and SK bioscience

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support